AlphaStocks
5.2
Consider Buy

CARDINAL HEALTH INC (CAH)

Health Care / Health Care Distributors

S&P 500

$196.95

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

#497out of 1126 in Health Care

Is CARDINAL HEALTH INC a Good Investment in 2026?

CARDINAL HEALTH INC (CAH) scores 5.2 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Lynch model rates CARDINAL HEALTH INC as Strong. The Greenblatt Magic Formula model is the least favorable, rating it Neutral. CARDINAL HEALTH INC currently trades above its estimated fair value of $150, suggesting limited upside at current prices. CARDINAL HEALTH INC ranks #497 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E30.5ROE-54.5Market Cap46BDiv Yield1.1

Estimated Fair Value

$149.8631% above

Trading above estimated fair value. Rapid eps growth (87%) partially justifies the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Strong

Growth rate vs price (PEG)

Greenblatt

Neutral

Top 10% (rank 1%)

Frequently Asked Questions

Is CARDINAL HEALTH INC (CAH) a good investment?
Based on AlphaStocks' composite analysis, CARDINAL HEALTH INC (CAH) scores 5.2 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading above estimated fair value. Rapid eps growth (87%) partially justifies the premium.
What is CARDINAL HEALTH INC's Piotroski F-Score?
CARDINAL HEALTH INC's Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is CAH overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $150, CAH appears overvalued. The stock currently trades 31% above its estimated fair value. Trading above estimated fair value. Rapid eps growth (87%) partially justifies the premium.
How does CAH compare to other Health Care stocks?
CARDINAL HEALTH INC ranks #497 out of 1126 stocks in the Health Care sector, placing it in the top 44% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about CAH?
AlphaStocks evaluates CAH using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Strong; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.2/10.

Similar Stocks

FTIPARRAZN

Compare CAH with

CAH vs FTICAH vs PARRCAH vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer